Matko Kalac

Enzalutamide with or without leuprolide in patiënten met high-risk biochemically recurrent prostate cancer: EMBARK po...

Talazoparib plus enzalutamide in men with HRR-deficient metastatic castration-resistant prostate cancer: final totale...

Talazoparib plus enzalutamide in men with metastatic castration-resistant prostate cancer: final totale overleving re...